01.08.2019

Bayer Appoints Jorge Levinson to manage the Pharmaceutical Business for Romania and Moldova

Bucharest, August 1st, 2019 – Bayer announces another top-level appointment effective starting August 2019. Jorge Levinson will lead the Pharmaceuticals Division, managing the business in Romania and the Republic of Moldova. He takes over from Cătălin Radu, who decided to pursue other professional opportunities.

Jorge Levinson has over 15 years of experience in the pharmaceutical industry. His professional journey included executive positions in various parts of the world, from Mexico, Spain, Germany and up to Ukraine, Morocco and Middle East.

 

„Ensuring patients’ access to our latest innovative treatments, growing our product portfolio to best suit their needs, fostering innovation and building trust are real priorities to us at Bayer, and I’m excited to serve this purpose in Romania. But there is so much more to tell. It’s our teams of professionals that make everything possible and I am committed to support them in reaching their maximum potential, so that we can grow alongside. An exciting chapter for our country group starts now that is for sure” stated Levinson at his appointment.

 

Jorge Levinson is original from Mexico, and holds master degrees in Business Administration, Computer Systems and Supply Chain Management.

 

 

 

 

About Bayer

 

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal year 2018, the Group employed around 117,000 people and had sales of 39.6 billion euros. Capital expenditures amounted to 2.6 billion euros, R&D expenses to 5.2 billion euros. For more information, go to www.bayer.com.

 

 

Note to editors:

Print-quality photos can be downloaded from our website at www.news.bayer.com 

 

TV and multimedia editors can download or order updated film footage about Bayer free of charge at www.tv-footage.bayer.com 

 

Contacts:

 

Radu Rotaru

E-Mail: radu.rotaru@bayer.com   

 

Petruţa Petcu

E-Mail: petruta.petcu@bdr.ro   

 

 

 

Forward-Looking Statements

This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.